⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL20449039 | 0.89 | HTT (0.46) | — | |
| SCHEMBL1157477 | 0.79 | HTT (0.58) | — | |
| SCHEMBL6300741 | 0.79 | HTT (0.58) | — | |
| Ammonia Solution, Strong SCHEMBL18151740 | 0.77 | HTT (0.56) | — | |
| SCHEMBL9799907 | 0.77 | — | — | |
| SCHEMBL13284444 | 0.76 | HTT (0.46) | — | |
| SCHEMBL1439963 | 0.75 | — | — | |
| SCHEMBL21034076 | 0.75 | — | — | |
| SCHEMBL27532488 | 0.75 | — | — | |
| SCHEMBL187487 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103347909-B | In order to prepare precursor compound of being connected on the radiopharmaceutic solid carrier of 18F and preparation method and application | 未来化学株式会社 | 2016-08-10 | — | — | CN | claimed |
| CN-103193858-B | The synthetic method of spiranostan glycoalkaloid | 中国海洋大学 | 2016-08-03 | — | — | CN | claimed |
| CN-108570053-A | Five yuan and 6-membered heterocyclic compound, preparation method, intermediate, combination and application | 中国科学院上海药物研究所 | 2018-09-25 | — | — | CN | disclosed |
| CN-103347909-B | In order to prepare precursor compound of being connected on the radiopharmaceutic solid carrier of 18F and preparation method and application | 未来化学株式会社 | 2016-08-10 | — | — | CN | disclosed |
| CN-103193858-B | The synthetic method of spiranostan glycoalkaloid | 中国海洋大学 | 2016-08-03 | — | — | CN | disclosed |
| EP-1463728-B1 | FUSED CYCLIC MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION | BRISTOL MYERS SQUIBB CO (US) | 2009-01-14 | — | — | EP | disclosed |
| US-7432267-B2 | Fused cyclic modulators of nuclear hormone receptor function | BRISTOL-MYERS SQUIBB COMAPNY (US) | 2008-10-07 | — | — | US | disclosed |
| US-7001911-B2 | Fused cyclic modulators of nuclear hormone receptor function | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-02-21 | — | — | US | disclosed |
| US-20050282813-A1 | Fused cyclic modulators of nuclear hormone receptor function | SALVATI MARK E | 2005-12-22 | — | — | US | disclosed |
| EP-1463728-A4 | FUSED CYCLIC MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION | BRISTOL MYERS SQUIBB CO (US) | 2005-12-21 | — | — | EP | disclosed |
| CN-1708500-A | Derivatives of [6, 7-dihydro-5H-imidazo [1, 2-alpha ] imidazole-3-sulfonylamino ] -propionamide and their use as inhibitors of the interaction between CAMs and white integrins | BOEHRINGER INGELHEIM PHARMA (US) | 2005-12-14 | — | — | CN | disclosed |
| CN-1454083-A | Selective androgen receptor modulators and methods of identification, design and use thereof | BRISTOL MYERS SQUIBB CO (US) | 2003-11-05 | — | — | CN | disclosed |
| WO-2003053354-A2 | FUSED CYCLIC MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-07-03 | — | — | WO | disclosed |
| US-20030114420-A1 | Fused cyclic modulators of nuclear hormone receptor function | BRISTOL-MYERS SQUIBB COMPANY | 2003-06-19 | — | — | US | disclosed |
| EP-1299385-A2 | FUSED CYCLIC MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION | Bristol-Myers Squibb Company (US) | 2003-04-09 | — | — | EP | disclosed |
| EP-1299094-A2 | SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR IDENTIFICATION, DESIGN AND USE | Bristol-Myers Squibb Company (US) | 2003-04-09 | — | — | EP | disclosed |
| US-20020173445-A1 | Selective androgen receptor modulators and methods for their identification, design and use | BRISTOL-MYERS SQUIBB COMPANY | 2002-11-21 | — | — | US | disclosed |
| WO-2002000617-A2 | SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR IDENTIFICATION, DESIGN AND USE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-01-03 | — | — | WO | disclosed |
| WO-2002000653-A2 | FUSED CYCLIC COMPOUNDS AS MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-01-03 | — | — | WO | disclosed |
| CN-1232451-A | Substd. cyclic amine metalloprotease inhibitors | PROCTER & GAMBLE (US) | 1999-10-20 | — | — | CN | disclosed |